Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
Go back to Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure| Tombstone Technologies, Inc. (NASDAQ: TMCI) | Delayed: 4.33 -0.11 (2.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.44 | 52 Week High | $3.25 | |||
| Open | $4.42 | 52 Week Low | $0.65 | |||
| Day High | $4.44 | P/E | N/A | |||
| Day Low | $4.26 | EPS | $-0.06 | |||
| Volume | 183,056 | |||||
